You are here

Caprelsa

Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial

BioSpace

Wed, 08/23/23 - 10:12 am

medullary thyroid cancer

clinical trials

AstraZeneca sells rare cancer drug to Sanofi for up to $300 million

Yahoo/Reuters

Mon, 07/27/15 - 10:00 am

medullary thyroid cancer

Tackling Cancer: Thyroid Cancer's Biggest Current and Upcoming Players

Motley Fool

Mon, 04/29/13 - 05:24 pm

ONYX Pharmaceuticals

JAMA says FDA jumped the gun on Gilenya, Pradaxa

Fierce Pharma

Thu, 09/6/12 - 09:33 am

Boehringer Ingelheim

First Orphan Launch a Challenge for AstraZeneca

PharmExec

Thu, 08/4/11 - 09:55 am